Initial management of low-risk localized prostate cancer in the UK: Analysis of the British Association of Urological Surgeons Cancer Registry

BJU International

Volumn 106, Issue 8, 2010, Pages 1161-1164

  McVey, Gerard P ^a   McPhail, Sean ^b   Fowler, Sarah ^c   McIntosh, Gregor ^d   Gillatt, David ^e   Parker, Chris C ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b South West Public Health Observatory   (United Kingdom)

^c British Association of Urological Surgeons   (United Kingdom)

^d SALISBURY NHS FOUNDATION TRUST   (United Kingdom)

^e NORTH BRISTOL NHS TRUST   (United Kingdom)

Author keywords

management; prostate cancer; socio economic status

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER REGISTRY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; SOCIOECONOMICS; UNITED KINGDOM;

AGED; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; EPIDEMIOLOGIC METHODS; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGISTRIES; SOCIOECONOMIC FACTORS; WATCHFUL WAITING;

EID: 77957577789     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09288.x     Document Type: Article

References (19)

1. Cancer Research UK, News and Resources Centre CancerStats. Prostate Cancer and Prostatic Diseases, 2008. Available at: http://info.cancerresearchuk. org/cancerstats/types/prostate/index.htm?script=true
2. Chism DB, Hanlon AL, Horwitz EM et al. A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy. Int J Radiat Oncol Biol Phys 2004 59 : 380 5
3. D'Amico AV, Whittington R, Malkowicz SB et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998 280 : 969 74
4. Zelefsky MJ, Fuks Z, Hunt M et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001 166 : 876 81
5. O'Donnell H, Parker C. What is low-risk prostate cancer and what is its natural history? World J Urol 2008 26 : 415 22
6. Cooperberg MR, Lubeck DP, Meng MV et al. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 2004 22 : 2141 9
7. Fleming IDCJ, Henson D. AJCC Cancer Staging Manual.
8. UK NHS. Postcode Directory (NHSPD) DSCN. 15200852008
9. Department for Communities and Local Government. The Indices of Deprivation. 2004
10. ONS. Lower Layer Super Output Areas, Small Area Population Estimates.
11. Melia J, Coulson P, Coleman D et al. Urological referral of asymptomatic men in general practice in England. Br J Cancer 2008 98 : 1176 81
12. Harlan SR, Cooperberg MR, Elkin EP et al. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. J Urol 2003 170 : 1804 7
13. Cooperberg M, Lubeck D, Mehta S et al. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). J Urol 2003 170 : S21 5
14. Smith EB, Frierson HF Jr., Mills SE et al. Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading? Cancer 2002 94 : 2282 7
15. Wu X, Chen VW, Andrews PA et al. Initial treatment patterns for clinically localized prostate cancer and factors associated with the treatment in Louisiana. J State Med Soc 2005 157 : 188 94
16. Krupski TL, Kwan L, Afifi AA et al. Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol 2005 23 : 7881 8
17. Hall HI, Satariano WA, Thompson T et al. Initial treatment for prostate carcinoma in relation to comorbidity and symptoms. Cancer 2002 95 : 2308 15
18. Harlan LC, Potosky A, Gilliland FD et al. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst 2001 93 : 1864 71
19. Donovan J, Hamdy F, Neal D et al. Prostate Testing for Cancer and Treatment (ProtecT) feasibility study. Health Technol Assess 2003 7 : 1 88